KALARIS THERAPEUTICS, INC. Shares Outstanding (Cover Page)
KALARIS THERAPEUTICS, INC. (KLRS) had Shares Outstanding (Cover Page) of 23.80 million shares as of 2026-08-04, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-04: Entity Common Stock, Shares Outstanding 23.80M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 23.79M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 22.93M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 18.70M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-08-04 | 23.80M shares 10-Q · filed 2026-08-11 | |
| 2026-05-05 | 23.79M shares 10-Q · filed 2026-05-12 | |
| 2026-03-10 | 22.93M shares 10-K · filed 2026-03-17 | |
| 2025-11-05 | 18.70M shares 10-Q · filed 2025-11-12 | |
| 2025-08-06 | 18.70M shares 10-Q · filed 2025-08-13 | |
| 2025-05-07 | 18.70M shares 10-Q · filed 2025-05-14 | |
| 2025-02-28 | 5.04M shares 10-K · filed 2025-03-07 | |
| 2024-11-05 | 115.54M shares 10-Q · filed 2024-11-12 | |
| 2024-08-02 | 115.37M shares 10-Q · filed 2024-08-09 | |
| 2024-05-06 | 115.00M shares 10-Q · filed 2024-05-13 | |
| 2024-03-08 | 114.87M shares 10-K · filed 2024-03-15 | |
| 2023-10-27 | 114.06M shares 10-Q · filed 2023-11-02 | |
| 2023-07-28 | 113.87M shares 10-Q · filed 2023-08-03 | |
| 2023-04-28 | 93.59M shares 10-Q · filed 2023-05-04 | |
| 2023-02-09 | 93.46M shares 10-K · filed 2023-02-15 | |
| 2022-10-28 | 93.16M shares 10-Q · filed 2022-11-03 | |
| 2022-07-29 | 93.06M shares 10-Q · filed 2022-08-04 | |
| 2022-04-29 | 65.42M shares 10-Q · filed 2022-05-05 | |
| 2022-02-04 | 65.35M shares 10-K/A · filed 2022-03-30 | |
| 2021-10-29 | 65.14M shares 10-Q · filed 2021-11-05 | |
| 2021-07-30 | 65.12M shares 10-Q · filed 2021-08-06 | |
| 2021-04-30 | 65.11M shares 10-Q · filed 2021-05-06 | |
| 2021-02-02 | 65.11M shares 10-K · filed 2021-02-12 | |
| 2020-11-09 | 65.11M shares 10-Q · filed 2020-11-10 | |
| 2020-08-31 | 65.11M shares 10-Q/A · filed 2020-09-16 | 21.57M shares 10-Q · filed 2020-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |